Ideal Option Now Offers Evidence-Based Treatment for Meth Addiction
Share Article
The treatment, shown effective in a study published by the New England Journal of Medicine, offers hope as the pandemic drives up methamphetamine use disorder. KENNEWICK, Wash. (PRWEB) March 09, 2021 Ideal Option, a national leader in evidence-based treatment for addiction to opioids, alcohol and polysubstances, is now offering medication-assisted treatment for isolated methamphetamine use disorder.
The treatment combines two medications: naltrexone, commonly used to treat alcohol and opioid dependence, and bupropion, an antidepressant.
In the past, the two medications have been studied separately for treating methamphetamine addiction, with little success. But the combination appears to be effective. In a 12-week NIH-funded study published in the New England Journal of Medicine (NEJM), 13.6% of patients who took both medica